Where to buy Melanotan-1 (MT-1) in the UK
Buying Melanotan-1 (MT-1) from a UK-based research peptide supplier: what to look for, what to avoid, and how Peptify compares on purity, dispatch, and transparency.
What to look for in a UK supplier
When buying Melanotan-1 (MT-1) for research purposes in the UK, prioritise suppliers that offer:
- Batch-specific COAs — not generic purity claims
- 99%+ HPLC purity — verified by a third-party laboratory
- UK-based dispatch — Royal Mail Tracked from a UK address
- Clear "for research use only" labelling — indicating MHRA-aware framing
- Transparent supply chain — no hidden sourcing claims, no fake certifications
- A real UK business address and contact — not a faceless dropshipper
Peptify UK meets all of these criteria.
Red flags to avoid
Be cautious of any peptide supplier that:
- Claims their product is "FDA approved" or "clinically proven" — both are illegal for research chemicals
- Uses fake trust badges (e.g., "Nutri Approved", "Medical-Grade") that are not verifiable
- Provides only generic or non-batch-specific COAs
- Offers prices significantly below market (usually a sign of under-dosing or wrong compound)
- Has no UK address or business registration
- Makes therapeutic claims or suggests human dosing
Why Peptify UK
Peptify is a UK-based research peptide supplier with:
- 99%+ HPLC-verified purity on every batch of Melanotan-1 (MT-1)
- Full third-party Janoshik COAs published per product page and downloadable directly
- UK dispatch via Royal Mail Tracked delivery
- UK bank transfer (Open Banking) and cryptocurrency payment methods
- Clear "research use only" framing on every touchpoint
Buy Melanotan-1 (MT-1) for research
99%+ HPLC-verified Melanotan-1 (MT-1) in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
What is the difference between MT-1 and MT-2?
MT-1 is a linear analogue of alpha-MSH that primarily targets MC1R for melanogenesis. MT-2 is a cyclic analogue with broader receptor activity.